Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 285
Countries 141
Faculty 358
Health Topics 122

Filter from the selections below

Clear All Filters

Filters: Drug and Vaccine Development 

Back to search

Resistance to M. tuberculosis

In endemic settings, some adults who are heavily and repeatedly exposed to M. tuberculosis never develop latent tuberculosis infection (LTBI) as defined by a positive tuberculin skin test (TST) or interferon gamma release assay (IGRA). These individuals, may "resist" M.tb infection.  We are part of an international consortium that is trying to understand the immune mechanisms underlying this clinical phenotype.  Our hope is that we will discover the immune mechanisms that are required for protective immunity to M.tb in humans.  This information can then be used to develop new therapies, including vaccines. 

Active Dates 
01/01/2018
Faculty Involved 
Health Topics